Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 674462

Use of phosphate-binding agents is associated with a lower risk of mortality


Cannata-Andía, J.B.; ...; Ćović, Adrian; ...; Pavlović, Draško; ...; Zoccali, C.
Use of phosphate-binding agents is associated with a lower risk of mortality // Kidney international, 84 (2013), 998-1008 doi:10.1038/ki.2013.185 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 674462 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Use of phosphate-binding agents is associated with a lower risk of mortality

Autori
Cannata-Andía, J.B. ; ... ; Ćović, Adrian ; ... ; Pavlović, Draško ; ... ; Zoccali, C.

Izvornik
Kidney international (0085-2538) 84 (2013); 998-1008

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
dialysis; hyperparathyroidism; hyperphosphatemia; mineral metabolism; mortality risk; phosphate binders

Sažetak
Hyperphosphatemia has been associated with higher mortality risk in CKD 5 patients receiving dialysis. Here, we determined the association between the use of single and combined phosphate- binding agents and survival in 6797 patients of the COSMOS study: a 3-year follow-up, multicenter, open-cohort, observational prospective study carried out in 227 dialysis centers from 20 European countries. Patient phosphate-binding agent prescriptions (time-varying) and the case- mix–adjusted facility percentage of phosphate- binding agent prescriptions (instrumental variable) were used as predictors of the relative all-cause and cardiovascular mortality using Cox proportional hazard regression models. Three different multivariate models that included up to 24 variables were used for adjustments. After multivariate analysis, patients prescribed phosphate-binding agents showed a 29 and 22% lower all-cause and cardiovascular mortality risk, respectively. The survival advantage of phosphate- binding agent prescription remained statistically significant after propensity score matching analysis. A decrease of 8% in the relative risk of mortality was found for every 10% increase in the case-mix–adjusted facility prescription of phosphate-binding agents. All single and combined therapies with phosphate-binding agents, except aluminum salts, showed a beneficial association with survival. The findings made in the present association study need to be confirmed by randomized controlled trials to prove the observed beneficial effect of phosphate-binding agents on mortality.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
219-2192376-2092 - Biomehanika čvrstih organskih tkiva (Nikolić, Vasilije, MZOS ) ( CroRIS)

Ustanove:
KBC "Sestre Milosrdnice",
Medicinski fakultet, Osijek

Profili:

Avatar Url Draško Pavlović (autor)

Poveznice na cjeloviti tekst rada:

Pristup cjelovitom tekstu rada doi www.nature.com

Citiraj ovu publikaciju:

Cannata-Andía, J.B.; ...; Ćović, Adrian; ...; Pavlović, Draško; ...; Zoccali, C.
Use of phosphate-binding agents is associated with a lower risk of mortality // Kidney international, 84 (2013), 998-1008 doi:10.1038/ki.2013.185 (međunarodna recenzija, članak, znanstveni)
Cannata-Andía, J., ..., Ćović, A., ..., Pavlović, D., ... & Zoccali, C. (2013) Use of phosphate-binding agents is associated with a lower risk of mortality. Kidney international, 84, 998-1008 doi:10.1038/ki.2013.185.
@article{article, author = {Cannata-And\'{\i}a, J.B. and \'{C}ovi\'{c}, Adrian and Pavlovi\'{c}, Dra\v{s}ko and Zoccali, C.}, year = {2013}, pages = {998-1008}, DOI = {10.1038/ki.2013.185}, keywords = {dialysis, hyperparathyroidism, hyperphosphatemia, mineral metabolism, mortality risk, phosphate binders}, journal = {Kidney international}, doi = {10.1038/ki.2013.185}, volume = {84}, issn = {0085-2538}, title = {Use of phosphate-binding agents is associated with a lower risk of mortality}, keyword = {dialysis, hyperparathyroidism, hyperphosphatemia, mineral metabolism, mortality risk, phosphate binders} }
@article{article, author = {Cannata-And\'{\i}a, J.B. and \'{C}ovi\'{c}, Adrian and Pavlovi\'{c}, Dra\v{s}ko and Zoccali, C.}, year = {2013}, pages = {998-1008}, DOI = {10.1038/ki.2013.185}, keywords = {dialysis, hyperparathyroidism, hyperphosphatemia, mineral metabolism, mortality risk, phosphate binders}, journal = {Kidney international}, doi = {10.1038/ki.2013.185}, volume = {84}, issn = {0085-2538}, title = {Use of phosphate-binding agents is associated with a lower risk of mortality}, keyword = {dialysis, hyperparathyroidism, hyperphosphatemia, mineral metabolism, mortality risk, phosphate binders} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font